I agree that this site is using cookies. You can find further informations here.
X
Kaltenboeck, A.
359  results:
Search for persons X
?
1

P.3.25 No evidence for antidepressant-like acute effects of..:

Kaltenboeck, A. ; Miketa, T. ; Breunhoelder, V...
European Neuropsychopharmacology.  29 (2019)  - p. S698 , 2019
Link: https://doi.org/10.1016/..
 
?
2

But Will They Trade Health? Developing An Economic Value Fr..:

Briggs, A ; Baba, C ; Lipitz-Snyderman, A...
Value in Health.  20 (2017)  9 - p. A707 , 2017
Link: https://doi.org/10.1016/..
 
?
3

Identifying Attributes of Cancer Treatments: What Do Stakeh..:

Baba, C ; Briggs, A ; Mcintosh, E...
Value in Health.  20 (2017)  9 - p. A774 , 2017
Link: https://doi.org/10.1016/..
 
?
4

Molecular characterization, phylogenetic analysis and expre..:

Feng, J. B. ; Liu, S. K. ; Wang, R. J....
Journal of Fish Biology.  86 (2015)  2 - p. 592-604 , 2015
Link: https://doi.org/10.1111/..
 
?
5

High‐density interspecific genetic linkage mapping provides..:

Liu, S. ; Li, Y. ; Qin, Z....
Animal Genetics.  47 (2015)  1 - p. 81-90 , 2015
Link: https://doi.org/10.1111/..
 
?
6

HEALTH CARE RESOURCE USE AMONG ADVANCED GASTRIC CANCER PATI..:

Rajan, N ; Cuyun Carter, G ; Kaltenboeck, A...
Value in Health.  17 (2014)  7 - p. A734 , 2014
Link: https://doi.org/10.1016/..
 
?
7

Daily Dose and Costs Associated With Maintenance Therapy of..:

Kaltenboeck, A. ; Boytsov, N. ; Hayes-Larson, E....
Value in Health.  17 (2014)  7 - p. A519 , 2014
Link: https://doi.org/10.1016/..
 
?
8

Health Care Resource Use And Costs In Patients With Type 2 ..:

Kaltenboeck, A. ; Ivanova, J. ; Thomas, N....
Value in Health.  16 (2013)  3 - p. A161 , 2013
Link: https://doi.org/10.1016/..
 
?
9

Indirect Comparison of Joint Damage Prevention with Adalimu..:

Wu, E.Q. ; Cifaldi, M. ; Diener, M....
Value in Health.  16 (2013)  7 - p. A555 , 2013
Link: https://doi.org/10.1016/..
 
?
10

PMD1 Economic Value of Screening for Early Parkinson's Dise..:

Johnson, S. ; Birnbaum, H.G. ; Kaltenboeck, A...
Value in Health.  15 (2012)  7 - p. A344-A345 , 2012
Link: https://doi.org/10.1016/..
 
?
11

PND26 Economic Value of Slowing Parkinson's Disease to Paye..:

Johnson, S. ; Diener, M. ; Kaltenboeck, A....
Value in Health.  15 (2012)  4 - p. A145 , 2012
Link: https://doi.org/10.1016/..
 
?
12

Direct costs and survival of medicare beneficiaries with ea..:

Kaltenboeck, A. ; Johnson, S.J. ; Davis, M.R....
Parkinsonism & Related Disorders.  18 (2012)  4 - p. 321-326 , 2012
Link: https://doi.org/10.1016/..
 
?
13

PND31 Economic Value of Slowing Parkinson's Disease in Germ..:

Johnson, S. ; Birnbaum, H.G. ; Kaltenboeck, A...
Value in Health.  15 (2012)  7 - p. A551 , 2012
Link: https://doi.org/10.1016/..
 
?
14

PND5 ASSESSMENT OF PARKINSON'S DISEAES PROGRESSION RATES BY..:

Johnson, S.J. ; Kaltenboeck, A. ; Diener, M...
Value in Health.  14 (2011)  3 - p. A202 , 2011
Link: https://doi.org/10.1016/..
 
?
15

OR3 THE DIRECT AND INDIRECT COSTS ASSOCIATED WITH HYPOGONAD..:

Kaltenboeck, A. ; Foster, S. ; Thomas, N....
Value in Health.  14 (2011)  3 - p. A4 , 2011
Link: https://doi.org/10.1016/..
 
1-15